Company intelligence / Profile preview

Hangzhou Lancet Robotics

Hangzhou, Zhejiang Sheng / Zhejiang Province, Chinalancet-robotics.com ↗

Ownership: Private
Development stage: Other

Overview

The company’s flagship product, the RobPath® Total Hip Application, is a semi-active robotic system designed to assist surgeons in total hip arthroplasty. It uses pre-operative CT imaging and haptic feedback to improve accuracy and safety. The device received FDA 510(k) clearance in December 2022 and is considered substantially equivalent to other leading systems such as the MAKO Total Hip Application. Clinical results indicate it meets safety and effectiveness criteria for its intended use[3].

Therapeutic areas: Other
Modalities: DeviceRobotic surgical system
Industry: Surgical Medical Devices

Partnerships

No major pharmaceutical or biotech partnerships are publicly disclosed as of June 2025.

Beyond the preview

Go deeper on Hangzhou Lancet Robotics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hangzhou Lancet Robotics.

Explore the full profile